StockNews.com Begins Coverage on Cutera (NASDAQ:CUTR)

Research analysts at StockNews.com started coverage on shares of Cutera (NASDAQ:CUTR) in a research report issued to clients and investors on Wednesday. The firm set a “sell” rating on the medical device company’s stock.

Cutera Stock Down 63.9 %

Shares of NASDAQ:CUTR opened at $0.04 on Wednesday. The company’s 50-day moving average price is $0.31 and its 200 day moving average price is $0.45. The company has a market cap of $787,254.00, a PE ratio of -0.01 and a beta of 1.36. Cutera has a fifty-two week low of $0.09 and a fifty-two week high of $3.00.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Cutera stock. Geode Capital Management LLC lifted its stake in shares of Cutera, Inc. (NASDAQ:CUTR) by 25.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 248,257 shares of the medical device company’s stock after acquiring an additional 50,046 shares during the quarter. Geode Capital Management LLC owned 1.23% of Cutera worth $88,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 90.70% of the company’s stock.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.